Browse by all authors Browse By Author ID - Alon Meizler

Browse Results (5 results found)

Subscribe to the RSS feed for this result setSubscribe to the RSS feed for this result set

Refine

  Abstract Views File Downloads Thomson Reuters Web of Science Citation Count Scopus Citation Count Altmetric Score
Pasay, Cielo, Rothwell, Jim, Mounsey, Kate, Kelly, Andrew, Hutchinson, Beverly, Miezler, Alon and McCarthy, James (2012) An exploratory study to assess the activity of the acarine growth inhibitor, fluazuron, against Sarcoptes scabei infestation in pigs. Parasites and Vectors, 5 1: 1-4. doi:10.1186/1756-3305-5-40 36   5 Cited 5 times in Scopus5 0
Giorgi, M., Meizler, A. and Mills, P. C. (2012). Development and validation of a new methodology to quantify the novel atypical opioid drug tapentadol in canine plasma by HPLC with spectrofluorimetric detection. In: Abstracts of the 12th International Congress of the European Association for Veterinary Pharmacology and Toxicology. 12th International Congress of the European Association for Veterinary Pharmacology and Toxicology (EAVPT 2012), Noordwijkerhout, The Netherlands, (88-88). 8-12 July 2012. doi:10.1111/jvp.12005 37   0 0
Giorgi, Mario, Meizler, Alon and Mills, Paul C. (2012) Pharmacokinetics of the novel atypical opioid tapentadol following oral and intravenous administration in dogs. Veterinary Journal, 194 3: 309-313. doi:10.1016/j.tvjl.2012.05.019 29   5 Cited 8 times in Scopus8 4
Giorgi, M., Meizler, A. and Mills, P. C. (2012). Pharmacokinetics of the novel atypical opioid tapentadol in dogs. In: Abstracts of the 12th International Congress of the European Association for Veterinary Pharmacology and Toxicology. 12th International Congress of the European Association for Veterinary Pharmacology and Toxicology (EAVPT 2012), Noordwijkerhout, The Netherlands, (68-68). 8-12 July 2012. doi:10.1111/jvp.12004 41   0 0
Giorgi, M., Meizler, A. and Mills, P. C. (2012) Quantification of tapentadol in canine plasma by HPLC with spectrofluorimetric detection: Development and validation of a new methodology. Journal of Pharmaceutical and Biomedical Analysis, 67-68 148-153. doi:10.1016/j.jpba.2012.04.020 41   8 Cited 11 times in Scopus11 0